Anebulo Pharmaceuticals, Inc. (ANEB)
0.3574
-0.03
(-8.36%)
USD |
OTCM |
Sep 09, 16:00
Anebulo Pharmaceuticals Total Liabilities (Quarterly) : 1.486M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.486M |
| September 30, 2025 | 0.9638M |
| June 30, 2025 | 0.4877M |
| March 31, 2025 | 0.546M |
| December 31, 2024 | 0.8788M |
| September 30, 2024 | 0.5692M |
| June 30, 2024 | 0.2606M |
| March 31, 2024 | 1.010M |
| December 31, 2023 | 1.014M |
| September 30, 2023 | 0.7166M |
| June 30, 2023 | 1.069M |
| March 31, 2023 | 1.491M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.372M |
| September 30, 2022 | 0.6982M |
| June 30, 2022 | 0.5125M |
| March 31, 2022 | 0.0858M |
| December 31, 2021 | 0.0499M |
| September 30, 2021 | 0.6077M |
| June 30, 2021 | 0.2416M |
| March 31, 2021 | 10.75M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 0.2239M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.422M |
| Shareholders Equity (Quarterly) | 7.936M |
| Current Ratio | 6.242 |